Insider Transactions Reported by 21 Insiders of Tharimmune, Inc.

Symbol
THAR on Nasdaq
Location
Bridgewater, NJ

Insiders trading volume in the past year

Tharimmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vincent LoPriore Executive Chairman, Director, 10%+ Owner $1,245,120 03 Nov 2025
Gravitas Capital LP 10%+ Owner $1,083,987 +$500,000 +86% 03 Nov 2025
Highpoint Pharmaceuticals LLC 10%+ Owner $489,028 11 Jan 2022
Kufe LLC 10%+ Owner $407,629 11 Jan 2022
Surender Kharbanda 10%+ Owner $362,784 11 Jan 2022
Varinder Kaur 10%+ Owner $328,489 11 Jan 2022
Sandeep Laumas 10%+ Owner $319,912 11 Jan 2022
Gary Stetz Director $172,296 03 Nov 2025
Sireesh Appajosyula CEO, Director $92,112 +$90,973 +7987% 03 Nov 2025
Randy Milby CEO, Director $37,172 13 Jan 2025
Kelly Anderson Director $10,017 23 Jun 2025
Sanam Parikh COO, Director $2,566 +$2,451 +2131% 03 Nov 2025
Thomas Hess Chief Financial Officer 11 Jan 2022
Mark Wendland Chief Executive Officer 06 Nov 2025
Leonard L. Mazur Director 09 Aug 2024
Lynne A. Bui Director 09 Aug 2024
James Liddy Director 03 Nov 2025
Clay Kahler Director 03 Nov 2025
Nancy Davis Rickel Director 03 Nov 2025
Mark Toomey President 06 Nov 2025
Dong Kim Cfo 27 Mar 2025

Recent Insider Transactions by Companies or Individuals for Tharimmune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.